margin 25.3% 18.1% Net profit margin 17.6% 11.9% Debt to Equity ratio 0.17 0.10 Earnings per share 0.66 0.46 ROA 13.1% 11.0% ROE 14.0% 10.9% Gross profit margin = Gross Profit (Total Sales – Costs of Sales
Profit - attributable to equity holders of the parent 14.56 24.26 (9.70) (39.98) Gross Profit Margin (%) 24.51 27.10 Net Profit Margin (%) 6.70 9.88 Unit: million Baht For 6-month period (Jan-Jun) 2020
- attributable to equity holders of the parent 24.15 30.57 (6.42) (21.00) Gross Profit Margin (%) 25.20 30.30 Net Profit Margin (%) 9.60 12.30 Unit: million Baht For 9-month period (Jan-Sep) 2019 2018 Change
in the gross profit margin that expanded from 15.3% in the third quarter of 2018 to 16.4% in the third quarter of 2019 and more efficient cost management that caused selling and administrative expense
THB 40.7 million or 24.9% and gross profit margin to total revenues was at 15.0%. The Group reported total net profit for the year 2017 at THB 50.4 million, decreased by THB 32.9 million or 39.5% when
เช่น พันธบัตร หุ้นกู้ ตั๋วสัญญาใช้เงิน บัตรเงินฝาก Letter of Credit และ Letter of Guarantee เป็นต้น 3. เงินให้กู้ยืมคงค้าง (margin loan) จำนวนเงินที่ลูกค้ากู้ยืมจากบริษัทหลักทรัพย์เพื่อซื้อหลักทรัพย์ 4
frequency of automobile use and consumption of oil to falter. 2. Net marketing margin declined compared to the previous quarter due to finished product cost rising following the hike of oil price in the
same period of 2017, due to the increasing of the quantity of Sales by 17%. 2. Cost of goods sold was Baht 1,275.68 million which the gross profit margin was decreased to 10.06% when compare to the same
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2